Costa, Eduardo
Mateus, Céu
Carter, Bernie
Saron, Holly
Eyton-Chong, Chin-Kien
Mehta, Fulya
Lane, Steven
Siner, Sarah
Dean, Jason
Barnes, Michael
McNally, Chris
Lambert, Caroline
Hollingsworth, Bruce
Carrol, Enitan D.
Sefton, Gerri
Funding for this research was provided by:
NIHR Invention for Innovation i4i Programme (II-LA-0216-20002, II-LA-0216-20002, II-LA-0216-20002, II-LA-0216-20002, II-LA-0216-20002, II-LA-0216-20002, II-LA-0216-20002, II-LA-0216-20002, II-LA-0216-20002, II-LA-0216-20002, II-LA-0216-20002, II-LA-0216-20002, II-LA-0216-20002, II-LA-0216-20002, II-LA-0216-20002)
Article History
Received: 23 September 2022
Accepted: 22 June 2023
First Online: 4 July 2023
Declarations
:
: Ethics approval was given for the study, by the North-West, Liverpool East Research Ethics Committee, REC 17/NW/0533, and the Health Research Authority (HRA) permission to proceed was issued, (IRAS ID:215339).All methods were carried out in accordance with relevant guidelines and regulations. Informed consent was collected for the families of children who are transferred to critical care following deterioration, so that additional data can be captured to ascertain the indirect financial cost to families associated with critical deterioration. The consent process incorporates statements about the use of anonymised data for publication. This consent to participate was approved by the North-West, Liverpool East Research Ethics Committee, REC 17/NW/0533.
: Not applicable.
: The authors declare no competing interests.